Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060759

EVP & Chief Tech Ops Officer sold 358 shares at $81.14 ($29,048)

From the SEC's structured data for this filing

Trades in this filing

Huang Dennis Karl · EVP & Chief Tech Ops Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-14 Sale : show line 1 in the form −358 $81.14 $29,048 40,148 D
Open-market sales · 358 sh · avg $81.14 · $29,048
Loading xslF345X03/doc4.xml…